Mingde Biotechnology: Intends to acquire 100% equity of Bekal, stock price fluctuations have not reached abnormal standards.

Mingde Biology announced that the company plans to purchase 100% equity of Wuhan Bokai'er Rescue Supplies Co., Ltd. held by Blue Sail Medical in cash. The transaction was first disclosed on December 31, 2025. In the 20 trading days before the first announcement date, the company's stock closing price accumulated a decline of -3.47%, while the Shenzhen Composite Index accumulated an increase of 3.10% and the Shenwan Medical Equipment Index accumulated a decline of -2.10%. Excluding the factors of the overall market and the same industry sector, the company's stock price accumulated declines were -6.57% and -1.37% respectively, which did not exceed 20% and did not constitute abnormal fluctuations.